SHC: Multiplikator Forward P/S Sotera Health
Sotera Health Company (SHC) is implementing automated radiation sterilization, eliminating manual labor. High regulatory barriers ensure absolute customer loyalty. The large-scale deployment of AI systems optimizes quality control. The forward P/S multiple reflects the dynamics of market expectations, with the current level sitting around 2.20, allowing for an assessment of the ratio between market capitalization and projected revenue.
Rincian metrik komprehensif lan analitis Sotera Health Company (SHC)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Rasio Total Utang marang Ekuitas Sotera Health Company|SHC - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Sotera Health|SHC - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Nordion|SHC - Utang jangka dawa|Utang jangka cendhak perusahaan Sotera Health|Likuiditas cepet soterahealth.com
- data bathi bisnis lan rasio investasi:
SHC - Bathi resik perusahaan|Bathi mangsa ngarep Sotera Health Company|SHC - Rasio rega pasar marang bathi resik|Pangali Forward P/E Sotera Health Company|SHC - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sotera Health Corp|SHC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Sotera Health|SHC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan soterahealth.com|SHC - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sotera Health Company
- statistik dodolan lan pendapatan perusahaan:
Ringkesan analisis perusahaan:soterahealth.com SHC
The forward P/S ratio compares the current market value of Sotera Health Company (SHC) with the expected revenue for the following year, determining the premium investors are willing to pay for future earnings. Within the oligopoly of the sterilization market, the forward P/S level reflects market confidence in the company's ability to maintain long-term contracts with pharma behemoths despite stringent environmental regulations.
Analisis pesaing
Multiplikator Forward P/S A (agilent.com)|Quest Corp (DGX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ILMN - Rasio rega marang prakiraan pendapatan|EXAS - Multiplikator Forward P/S|RVTY (Revvity) - Multiplikator forward rega marang pendapatan|Bio-Rad - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan anbio.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep QuidelOrtho Inc. QDEL|Multiplikator Forward P/S OPK|CareDx - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S MRVI (Maravai LifeSciences Holdings)|Rasio rega marang pendapatan sing dikarepake FLGT (Fulgent Corp)|LAB: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Cytek Corp CTKB|OSUR (OraSure Technologies Inc) - Multiplikator forward rega marang pendapatan|Multiplikator forward rega marang pendapatan Exagen Inc.|Multiplikator forward rega marang pendapatan MDXH|LUCD - Prakiraan rega marang pendapatan|Rasio rega marang prakiraan pendapatan Prenetics (PRE)|Rasio rega marang prakiraan pendapatan IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech - Multiplikator forward rega marang pendapatan|prophaselabs.com - Rasio rega marang prakiraan pendapatan|AIMD - Rasio rega marang prakiraan pendapatan|Co-Diagnostics Inc (CODX) - Multiplikator forward rega marang pendapatan|HSCS: Multiplikator Forward P/S|BMRA - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan CDIO|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep onconetix.gcs-web.com ONCO|Rasio rega marang prakiraan pendapatan Virax Biolabs (VRAX)|Rasio rega marang pendapatan sing dikarepake BJDX|Rasio rega marang prakiraan pendapatan Vermillion AWH|Accelerate Diagnostics Inc (AXDX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|centogene.com - Multiplikator Forward P/S|ENZ (Enzo Biochem Inc.) - Kapitalisasi marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep FRES|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep GTG Labs (GENE)|ME (23andme.com) - Multiplikator Forward P/S|Multiplikator Forward P/S Psychemedics Inc
